查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1439582

經導管二尖瓣修復裝置 - 全球市場回顧、競爭格局、市場預測（2030）

Transcatheter Mitral Valve Repair Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030
出版日期: 按訂單生產 | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

2023年全球經導管二尖瓣修復器材市場規模將達11.9706億美元，到2030年將達到27.5671億美元，複合年增長率預計為14.95%。 經導管二尖瓣修復裝置的需求主要是由於二尖瓣狹窄、二尖瓣脫垂和二尖瓣逆流等心臟瓣膜疾病的日益流行所推動的。 此外，預計2024年至2030年冠狀動脈疾病、心肌梗塞、充血性心臟衰竭和心絞痛等心血管疾病的盛行率將增加，產品開發的技術創新以及產品上市和批准的增加將有助於整體成長在此期間的經導管二尖瓣修復裝置市場。

經導管二尖瓣修復裝置的市場動態

受多種因素影響，經導管二尖瓣修復裝置市場的產品需求正在增長，其中主要因素之一是二尖瓣狹窄、二尖瓣脫垂、二尖瓣關閉不全等。心臟瓣膜疾病的患病率不斷增加。

英國心臟基金會(BHF) 預測，到2023 年，由於生活方式的改變、老化和人口增長，到2022 年，全球將有大約5.5 億人患有心臟病和循環系統疾病。我報告過。

此外，根據世界衛生組織 (WHO) (2020) 的數據，全球有 900 萬人患有鈣化主動脈瓣狹窄。 此外，根據John Muir Health的統計，2020年美國約有150萬人受到主動脈瓣狹窄的影響，其中約50萬人患有嚴重主動脈瓣狹窄。 據同一消息來源稱，2020年，美國約有25萬名主動脈瓣狹窄患者出現症狀。 因此，包括各種心臟瓣膜疾病在內的心血管疾病的盛行率不斷增加，增加了對經導管二尖瓣修復裝置的需求。

患者對微創手術的偏好不斷增加，預計也預示著預測期內市場的成長。 經導管二尖瓣修復裝置以微創方式提供優於傳統手術的優勢，包括更快的恢復時間、更少的手術後疼痛、更短的住院時間、更少的傷口併發症和更好的傷口假體。

此外，產品發布和批准的增加將對市場產生積極影響。 例如，2019年3月，美國食品藥物管理局（FDA）批准了由雅培公司開發的MitraClip。 該裝置用作心臟瓣膜修復裝置，以緩解中度至重度或重度二尖瓣逆流。 這是一種微創醫療程序，需要 1 至 3 小時。

因此，上述因素將有助於 2024-2030 年預測期內經導管二尖瓣修復裝置市場的成長。

然而，在 2024-2030 年預測期內，與經導管二尖瓣修復相關的風險可能會抑制經導管二尖瓣修復器械市場的成長。

隨著封鎖法規的實施作為遏制 COVID-19 傳播的必要措施，經導管二尖瓣修復裝置市場經歷了暫時的衰退。 由於入院和診所接受心臟手術等手術的患者人數下降，對經導管二尖瓣修復裝置的需求受到阻礙。 此外，由於嚴格的封鎖規則和資源缺乏，製造和研發活動已經停止。 然而，隨著活動的恢復、世界各地疫苗的接種以及患者從醫院診斷和心臟手術中康復，對經導管二尖瓣修復裝置的需求顯著增加。 因此，預計上述因素將推動大流行期間對經導管二尖瓣修復裝置的需求，並且在預測期內該需求將會成長。

經導管二尖瓣修復裝置細分市場分析

就經導管二尖瓣修復裝置市場的產品細分而言，生物組織瓣膜類別預計將在 2023 年獲得可觀的收入份額。 這是由於該部分提供的好處以及二尖瓣逆流盛行率的增加。

本報告提供了全球經導管二尖瓣修復裝置市場的研究和分析，包括市場規模和預測、驅動因素和挑戰以及公司和產品概況。

目錄

第1章經導管二尖瓣修復裝置市場報告簡介

第2章經導管二尖瓣修復裝置市場執行摘要

  • 調查範圍
  • 市場概覽
  • 競爭評估

第3章監理分析

  • 美國
  • 歐洲
  • 日本
  • 中國

第4章經導管二尖瓣修復器材市場主要因素分析

  • 經導管二尖瓣修復裝置市場驅動因素
    • 瓣膜性心臟病的盛行率不斷上升
    • 人們對微創手術的興趣與日俱增
  • 經導管二尖瓣修復器材市場的限制與挑戰
    • 術後併發症的風險
  • 經導管二尖瓣修復裝置的市場機會
    • 管道中存在大量恢復設備

第5章波特五力分析經導管二尖瓣修補器材市場

第6章經導管二尖瓣修復器材市場佈局

  • 依類型
    • 機械閥
    • 生物組織（生物）瓣膜
  • 依指示
    • 二尖瓣關閉不全
    • 二尖瓣狹窄
    • 其他
  • 按最終用戶
    • 醫院、診所
    • 門診手術中心
  • 按地區
    • 北美
    • 歐洲
    • 亞太地區
    • 其他領域

第7章經導管二尖瓣修復器材市場公司及產品概況

  • Abbott
  • Edwards Lifesciences Corporation.
  • Shockwave Medical, Inc.
  • LivaNova PLC
  • NeoChord, Inc.
  • Coramaze Technologies
  • CryoLife, Inc.
  • Auto Tissue Berlin GmbH.
  • Medtronic
  • Boston Scientific Corporation
  • JenaValve Technology, Inc

第8章KOL瀏覽量

第 9 章專案方法

第 10 章關於 DelveInsight

第 11 章免責聲明與聯絡我們

Product Code: DIMDCL0411

Transcatheter Mitral Valve Repair Devices Market By Product (Mechanical Valve And Bioprosthetic Tissue Valve), Indication (Mitral Valve Regurgitation, Mitral Valve Stenosis, And Others), End-User (Hospitals & Clinics, Ambulatory Surgical Centers, And Others), and geography is expected to grow at a steady CAGR forecast till 2030 owing to the increasing prevalence of heart valve diseases and the growing demand for minimally invasive surgeries across the globe

The global transcatheter mitral valve repair devices market was valued at USD 1,197.06 million in 2023, growing at a CAGR of 14.95% during the forecast period from 2024 to 2030 to reach USD 2,756.71 million by 2030. The demand for transcatheter mitral valve repair devices is primarily being boosted by the increasing prevalence of heart valve diseases such as mitral valve stenosis, mitral valve prolapse, mitral valve regurgitation, and others. Further, the increasing prevalence of coronary artery disease, myocardial infarction, congestive heart failures, angina pectoris, and other cardiovascular diseases, along with innovation in product development and rising product launches and approvals are thereby contributing to the overall growth of the transcatheter mitral valve repair devices market during the forecast period from 2024-2030.

Transcatheter Mitral Valve Repair Devices Market Dynamics:

The transcatheter mitral valve repair devices market is witnessing a growth in product demand owing to various factors, one of the key factors being the increase in the prevalence of heart valve diseases such as mitral valve stenosis, mitral valve prolapse, mitral valve regurgitation, and others.

According to the British Heart Foundation (BHF), it was reported in 2023, that around 550 million people in 2022 were living with heart and circulatory diseases across the world owing to changing lifestyles, aging, and a growing population.

Further, according to the World Health Organization (WHO) 2020, the prevalence of calcific aortic valve stenosis was 9 million across the world. Also, as per the John Muir Health statistics, in the year 2020, about 1.5 million people in the United States suffered from aortic stenosis, and about 500,000 people within this group of patients suffered from severe aortic stenosis. As per the same source in 2020, about 250,000 patients suffering from aortic stenosis were symptomatic in the United States. Thus, the increasing prevalence of cardiovascular diseases including various heart valve diseases will increase the demand for transcatheter mitral valve repair devices.

The increasing patient preference for minimally invasive surgeries is also likely to bode well for the market growth during the forecast period. Transcatheter mitral valve repair devices offer advantages over conventional surgeries owing to their minimally invasive approach, such as shorter recovery time, less post-operational pain, less stay at the hospital, fewer wound complications, and better wound prosthesis.

Further, the rising product launches and approvals will create a positive impact on the market. For instance, in March 2019, the US Food and Drug Administration (FDA) approved MitraClip, developed by Abbott. The device is used as a heart valve repair device that was intended to reduce moderate-to-severe or even severe mitral regurgitation. It is a minimally invasive medical procedure and takes only 1-3 hours.

Therefore, the above-mentioned factors are contributing to the growth of the Transcatheter mitral valve repair devices market during the forecast period from 2024-2030.

However, risks associated with transcatheter mitral valve repair procedures and others may restrict the transcatheter mitral valve repair devices' market growth during the forecast period from 2024-2030.

The transcatheter mitral valve repair devices market experienced a period of a temporary setback as lockdown restrictions were enforced as a necessary step to curb the spread of COVID-19. The demand for transcatheter mitral valve repair devices was disrupted owing to the decline in the number of patients in hospitals & clinics for surgeries such as cardiac surgery. Moreover, manufacturing and research & development activities were halted owing to the imposition of strict lockdown rules and due to a lack of resources. However, with the resumption of various activities and with the administration of vaccines across different regions of the world, the demand for transcatheter mitral valve repair devices increased significantly with the resumption of patients in hospitals for diagnosis and heart surgeries. Henceforth, the aforementioned factors propelled the demand for transcatheter mitral valve repair devices during the pandemic and are estimated to grow similarly during the forecast period.

Transcatheter Mitral Valve Repair Devices Market Segment Analysis:

Transcatheter Mitral Valve Repair Devices Market by Product (Mechanical Valve and Bioprosthetic Tissue Valve), Indication (Mitral Valve Regurgitation, Mitral Valve Stenosis, and Others), End-User (Hospitals & Clinics, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the product segment of the transcatheter mitral valve repair devices market, the bioprosthetic tissue valve category is expected to amass significant revenue share in the year 2023. This can be ascribed to the advantages offered by the segment and the increasing prevalence of mitral valve regurgitation cases.

Bioprosthetic valves commonly used in clinical practice are called heterografts, which are usually stented or stentless porcine or bovine tissue valves. The bioprosthetic tissue valve category has higher efficacy as compared to the mechanical valve. The main advantage of bioprosthetic valves is that they do not require lifelong warfarin therapy, due to their lower thrombotic risk compared with mechanical valves.

Also, patients with bioprosthetic valves have a significantly decreased risk of bleeding.

Further, the increasing prevalence of heart valve diseases will increase the demand for bioprosthetic tissue valve devices. For instance, according to the Centers for Disease Control and Prevention (CDC) (2019), it was reported that in 2019, about 2.5% of the US population had valvular heart disease, being more common among the older population. Thus, the growing prevalence of valvular heart disease is expected to increase the demand for bioprosthetic tissue valve devices, thereby increasing the overall market growth.

Further, the increasing product launches and approvals and other strategic activities will in turn propel the demand for bioprosthetic tissue valve devices. For instance, in September 2021, Abbott received US FDA approval for Epic Plus and Epic Plus Supra Stented Tissue Valves to improve therapy options for people suffering from aortic or mitral valve disease. Epic Plus, a bioprosthetic valve, do not require long-term use of blood-thinner medication, making them the recommended option for people, especially aged over 70 years who are at risk of taking blood thinners.

Therefore, the advantages offered by bioprosthetic tissue valve devices along with the rising product launches are predicted to contribute to the increasing demand for this category, thereby driving the growth of the overall transcatheter mitral valve repair devices market during the forecast period.

North America is expected to dominate the overall Transcatheter Mitral Valve Repair Devices Market:

Among all the regions, North America is estimated to account for the largest share of the transcatheter mitral valve repair devices market in the year 2023. Owing to the factors such as the rising prevalence of heart valve diseases such as mitral valve stenosis, mitral valve prolapses, and mitral valve regurgitation. Apart from this, rising incidences of cardiovascular diseases such as strokes, and coronary artery diseases, among others, the rising burden of elderly patients prone to cardiovascular diseases, rising product approvals and launches, and escalating technological advancements are driving the North America transcatheter mitral valve repair devices market and is expected to witness positive growth.

According to the Canadian Cardiovascular Society (2023), it was reported that in 2022, 2.5% of the population had heart valve diseases, which is increasing significantly after the age of 65, reaching up to 13% after the age of 75. It was also estimated by the same source that in 2040, Canada will have an estimated 1.5 million people over 65 years with heart valve disease (HVD).

According to CDC (2019), it was reported that each year, about 805,000 people in the United States had a heart attack. Also, according to American Heart Association (2023), 20% of older Americans suffer from aortic stenosis, a common valve disease, each year.

Therefore, in such cases, transcatheter mitral valve repair device systems prove to be beneficial for the treatment of large patient pools suffering from heart valve diseases and other cardiovascular diseases, hence driving the demand and overall regional market of transcatheter mitral repair devices during the forecast period (2024-2030).

Coupled with the factors mentioned above, the increasing planned activities by the key players will also drive the market of transcatheter mitral valve repair devices. For instance, in September 2022, Edwards Lifesciences received FDA approval for its Pascal Precision system. The device used minimally invasive surgery to repair the mitral valve in patients with degenerative mitral regurgitation, a condition where the valve between heart chambers does not close completely, allowing blood to leak back through. Thus, such strategic steps help to increase the demand for transcatheter mitral valve repair devices, thereby driving the North America transcatheter mitral valve repair devices market forward during the forecast period.

Transcatheter Mitral Valve Repair Devices Market Key Players:

Some of the key market players operating in the transcatheter mitral valve repair devices market include Abbott, Edwards Lifesciences Corporation., Shockwave Medical, Inc., LivaNova PLC, NeoChord, Inc., Coramaze Technologies, CryoLife, Inc., Auto Tissue Berlin GmbH., Medtronic, Boston Scientific Corporation, JenaValve Technology, Inc., and others.

Recent Developmental Activities in the Transcatheter Mitral Valve Repair Devices Market:

In January 2023, Shockwave Medical, Inc., acquired Neovasc Inc., a company focused on the minimally invasive treatment of refractory angina, which is a chronic condition wherein a patient suffers chest pain that cannot be controlled by conventional therapies.

In January 2020, Abbott received CE Mark for its Tendyne Transcatheter Mitral Valve Implantation (TMVI) system for the treatment of mitral regurgitation (MR) in patients requiring a heart valve replacement and provides a safer option for candidates not willing to opt for open-heart surgery or transcatheter mitral valve repair.

Key Takeaways from the Transcatheter Mitral Valve Repair Devices Market Report Study

Market size analysis for current transcatheter mitral valve repair devices market size (2023), and market forecast for 5 years (2024-2030)

The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the transcatheter mitral valve repair devices market.

Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years

Key companies dominating the global transcatheter mitral valve repair devices market.

Various opportunities available for the other competitor in the transcatheter mitral valve repair devices market space.

What are the top-performing segments in 2023? How these segments will perform in 2030.

Which are the top-performing regions and countries in the current transcatheter mitral valve repair devices market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for transcatheter mitral valve repair devices market growth in the coming future?

Target Audience who can be benefited from this Transcatheter Mitral Valve Repair Devices Market Report Study

Transcatheter mitral valve repair devices products providers

Research organizations and consulting companies

Transcatheter mitral valve repair devices-related organizations, associations, forums, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders dealing in transcatheter mitral valve repair devices

Various End-users who want to know more about the transcatheter mitral valve repair devices market and the latest technological developments in the transcatheter mitral valve repair devices market.

Frequently Asked Questions for the Transcatheter Mitral Valve Repair Devices Market:

1. What are transcatheter mitral valve repair devices?

Transcatheter mitral valve repair devices are cardiac surgical devices that are used to treat heart valve diseases such as regurgitation, stenosis, and prolapse. Transcatheter mitral valve treatment is a minimally invasive procedure to replace a mitral valve that is not working properly.

2. What is the market for global transcatheter mitral valve repair devices?

The global transcatheter mitral valve repair devices market was valued at USD 1,197.06 million in 2023, growing at a CAGR of 14.95% during the forecast period from 2024 to 2030 to reach USD 2,756.71 million by 2030.

3. What are the drivers for the global transcatheter mitral valve repair devices market?

The demand for transcatheter mitral valve repair devices is primarily being heightened by the increasing prevalence of heart valve diseases, increasing prevalence of coronary artery disease, myocardial infarction, congestive heart failures, angina pectoris, and others. In addition, rising awareness and demand for minimally invasive devices, the increasing novel product launches and approvals, and innovation in product development thereby contribute to the overall growth of the transcatheter mitral valve repair devices market during the forecast period from 2024-2030.

4. Who are the key players operating in the global transcatheter mitral valve repair devices market?

Some of the key market players operating in the transcatheter mitral valve repair devices market include Abbott, Edwards Lifesciences Corporation., Shockwave Medical, Inc., LivaNova PLC, NeoChord, Inc., Coramaze Technologies, CryoLife, Inc., Auto Tissue Berlin GmbH., Medtronic, Boston Scientific Corporation, JenaValve Technology, Inc., and others.

5. Which region has the highest share in the transcatheter mitral valve repair devices market?

North America is expected to dominate the overall transcatheter mitral valve repair devices market during the forecast period from 2024-2030. Factors such as the rising prevalence of heart valve diseases, the increasing geriatric population prone to cardiovascular diseases, the rising number of risk factors, collaborations, acquisitions, partnerships among key market players in the market, and other factors are expected to drive the growth of the North American transcatheter mitral valve repair devices market.

Table of Contents

1.Transcatheter Mitral Valve Repair Devices Market Report Introduction

2. Transcatheter Mitral Valve Repair Devices Market Executive Summary

  • 2.1. Scope of the Study
  • 2.2. Market at Glance
  • 2.3. Competitive Assessment

3. Regulatory Analysis

  • 3.1. The United States
  • 3.2. Europe
  • 3.3. Japan
  • 3.4. China

4. Transcatheter Mitral Valve Repair Devices Market Key Factors Analysis

  • 4.1. Transcatheter Mitral Valve Repair Devices Market Drivers
    • 4.1.1. Rising prevalence of heart valve diseases
    • 4.1.2. Increasing preference for minimally invasive surgeries
  • 4.2. Transcatheter Mitral Valve Repair Devices Market Restraints and Challenges
    • 4.2.1. Risks of post-operational complications
  • 4.3. Transcatheter Mitral Valve Repair Devices Market Opportunities
    • 4.3.1. Presence of a robust number of repair devices in the pipeline

5. Transcatheter Mitral Valve Repair Devices Market Porter's Five Forces Analysis

  • 5.1. Bargaining Power of Suppliers
  • 5.2. Bargaining Power of Consumers
  • 5.3. Threat of New Entrants
  • 5.4. Threat of Substitutes
  • 5.5. Competitive Rivalry

6. Transcatheter Mitral Valve Repair Devices Market Layout

  • 6.1. By Type
    • 6.1.1. Mechanical Valve
    • 6.1.2. Bioprosthetic Tissue (Biological) Valve
  • 6.2. By Indication
    • 6.2.1. Mitral Valve Regurgitation
    • 6.2.2. Mitral Valve Stenosis
    • 6.2.3. Others
  • 6.3. By End-User
    • 6.3.1. Hospitals & Clinics
    • 6.3.2. Ambulatory Surgical Centers
    • 6.3.3. Others
  • 6.4. By Geography
    • 6.4.1. North America
      • 6.4.1.1. United States Transcatheter Mitral Valve Repair Devices Market Size in USD million (2021-2030)
      • 6.4.1.2. Canada Transcatheter Mitral Valve Repair Devices Market Size in USD million (2021-2030)
      • 6.4.1.3. Mexico Transcatheter Mitral Valve Repair Devices Market Size in USD million (2021-2030)
    • 6.4.2. Europe
      • 6.4.2.1. France Transcatheter Mitral Valve Repair Devices Market Size in USD million (2021-2030)
      • 6.4.2.2. Germany Transcatheter Mitral Valve Repair Devices Market Size in USD million (2021-2030)
      • 6.4.2.3. United Kingdom Transcatheter Mitral Valve Repair Devices Market Size in USD million (2021-2030)
      • 6.4.2.4. Italy Transcatheter Mitral Valve Repair Devices Market Size in USD million (2021-2030)
      • 6.4.2.5. Spain Transcatheter Mitral Valve Repair Devices Market Size in USD million (2021-2030)
      • 6.4.2.6. Rest of Europe Transcatheter Mitral Valve Repair Devices Market Size in USD million (2021-2030)
    • 6.4.3. Asia-Pacific
      • 6.4.3.1 China Transcatheter Mitral Valve Repair Devices Market Size in USD million (2021-2030)
      • 6.4.3.2. Japan Transcatheter Mitral Valve Repair Devices Market Size in USD million (2021-2030)
      • 6.4.3.3. India Transcatheter Mitral Valve Repair Devices Market Size in USD million (2021-2030)
      • 6.4.3.4. Australia Transcatheter Mitral Valve Repair Devices Market Size in USD million (2021-2030)
      • 6.4.3.5. South Korea Transcatheter Mitral Valve Repair Devices Market Size in USD million (2021-2030)
      • 6.4.3.6. Rest of Asia-Pacific Transcatheter Mitral Valve Repair Devices Market Size in USD million (2021-2030)
    • 6.4.4. Rest of the World (RoW)
      • 6.4.4.1. Middle East Transcatheter Mitral Valve Repair Devices Market Size in USD million (2021-2030)
      • 6.4.4.2. Africa Transcatheter Mitral Valve Repair Devices Market Size in USD million (2021-2030)
      • 6.4.4.3. South America Transcatheter Mitral Valve Repair Devices Market Size in USD million (2021-2030)

7. Transcatheter Mitral Valve Repair Devices Market Company and Product Profiles

  • 7.1. Abbott
    • 7.1.1. Company Overview
    • 7.1.2. Company Snapshot
    • 7.1.3. Financial Overview
    • 7.1.4. Product Listing
    • 7.1.5. Entropy
  • 7.2. Edwards Lifesciences Corporation.
    • 7.2.1. Company Overview
    • 7.2.2. Company Snapshot
    • 7.2.3. Financial Overview
    • 7.2.4. Product Listing
    • 7.2.5. Entropy
  • 7.3. Shockwave Medical, Inc.
    • 7.3.1. Company Overview
    • 7.3.2. Company Snapshot
    • 7.3.3. Financial Overview
    • 7.3.4. Product Listing
    • 7.3.5. Entropy
  • 7.4. LivaNova PLC
    • 7.4.1. Company Overview
    • 7.4.2. Company Snapshot
    • 7.4.3. Financial Overview
    • 7.4.4. Product Listing
    • 7.4.5. Entropy
  • 7.5. NeoChord, Inc.
    • 7.5.1. Company Overview
    • 7.5.2. Company Snapshot
    • 7.5.3. Financial Overview
    • 7.5.4. Product Listing
    • 7.5.5. Entropy
  • 7.6. Coramaze Technologies
    • 7.6.1. Company Overview
    • 7.6.2. Company Snapshot
    • 7.6.3. Financial Overview
    • 7.6.4. Product Listing
    • 7.6.5. Entropy
  • 7.7. CryoLife, Inc.
    • 7.7.1. Company Overview
    • 7.7.2. Company Snapshot
    • 7.7.3. Financial Overview
    • 7.7.4. Product Listing
    • 7.7.5. Entropy
  • 7.8. Auto Tissue Berlin GmbH.
    • 7.8.1. Company Overview
    • 7.8.2. Company Snapshot
    • 7.8.3. Financial Overview
    • 7.8.4. Product Listing
    • 7.8.5. Entropy
  • 7.9. Medtronic
    • 7.9.1. Company Overview
    • 7.9.2. Company Snapshot
    • 7.9.3. Financial Overview
    • 7.9.4. Product Listing
    • 7.9.5. Entropy
  • 7.10. Boston Scientific Corporation
    • 7.10.1. Company Overview
    • 7.10.2. Company Snapshot
    • 7.10.3. Financial Overview
    • 7.10.4. Product Listing
    • 7.10.5. Entropy
  • 7.11. JenaValve Technology, Inc
    • 7.11.1. Company Overview
    • 7.11.2. Company Snapshot
    • 7.11.3. Financial Overview
    • 7.11.4. Product Listing
    • 7.11.5. Entropy

8. KOL Views

9. Project Approach

10. About DelveInsight

11. Disclaimer & Contact Us

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: COVID-19 Impact Analysis
  • Table 3: Transcatheter mitral valve repair Devices Market in Global (2021-2030)
  • Table 4: Transcatheter mitral valve repair Devices Market in Global by Type (2021-2030)
  • Table 5: Transcatheter mitral valve repair Devices Market in Global by Indication (2021-2030)
  • Table 6: Transcatheter mitral valve repair Devices Market in Global by End-User (2021-2030)
  • Table 7: Transcatheter mitral valve repair Devices Market in Global by Geography (2021-2030)
  • Table 8: Transcatheter mitral valve repair Devices Market in North America (2021-2030)
  • Table 9: Transcatheter mitral valve repair Devices Market in North America by Country (2021-2030)
  • Table 10: Transcatheter mitral valve repair Devices Market in the US (2021-2030)
  • Table 11: Transcatheter mitral valve repair Devices Market in Canada (2021-2030)
  • Table 12: Transcatheter mitral valve repair Devices Market in Mexico (2021-2030)
  • Table 13: Transcatheter mitral valve repair Devices Market in Europe (2021-2030)
  • Table 14: Transcatheter mitral valve repair Devices Market in Europe by Country (2021-2030)
  • Table 15: Transcatheter mitral valve repair Devices Market in France (2021-2030)
  • Table 16: Transcatheter mitral valve repair Devices Market in Germany (2021-2030)
  • Table 17: Transcatheter mitral valve repair Devices Market in the United Kingdom (2021-2030)
  • Table 18: Transcatheter mitral valve repair Devices Market in Italy (2021-2030)
  • Table 19: Transcatheter mitral valve repair Devices Market in Spain (2021-2030)
  • Table 20: Transcatheter mitral valve repair Devices Market in the Rest of Europe (2021-2030)
  • Table 21: Transcatheter mitral valve repair Devices Market in Asia-Pacific (2021-2030)
  • Table 22: Transcatheter mitral valve repair Devices Market in Asia-Pacific by Country (2021-2030)
  • Table 23: Transcatheter mitral valve repair Devices Market in China (2021-2030)
  • Table 24: Transcatheter mitral valve repair Devices Market in Japan (2021-2030)
  • Table 25: Transcatheter mitral valve repair Devices Market in India (2021-2030)
  • Table 26: Transcatheter mitral valve repair Devices Market in Australia (2021-2030)
  • Table 27: Transcatheter mitral valve repair Devices Market in South Korea (2021-2030)
  • Table 28: Transcatheter mitral valve repair Devices Market in Rest of Asia-Pacific (2021-2030)
  • Table 29: Transcatheter mitral valve repair Devices Market in the Rest of the World (2021-2030)
  • Table 30: Transcatheter mitral valve repair Devices Market in RoW by Region (2021-2030)
  • Table 31: Transcatheter mitral valve repair Devices Market in the Middle East (2021-2030)
  • Table 32: Transcatheter mitral valve repair Devices Market in Africa (2021-2030)
  • Table 33: Transcatheter mitral valve repair Devices Market in South America (2021-2030)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: COVID-19 Impact Analysis
  • Figure 3: Transcatheter mitral valve repair Devices Market in Global (2021-2030)
  • Figure 4: Transcatheter mitral valve repair Devices Market in Global by Type (2021-2030)
  • Figure 5: Transcatheter mitral valve repair Devices Market in Global by Indication (2021-2030)
  • Figure 6: Transcatheter mitral valve repair Devices Market in Global by End-User (2021-2030)
  • Figure 7: Transcatheter mitral valve repair Devices Market in Global by Geography (2021-2030)
  • Figure 8: Transcatheter mitral valve repair Devices Market in North America (2021-2030)
  • Figure 9: Transcatheter mitral valve repair Devices Market in North America by Country (2021-2030)
  • Figure 10: Transcatheter mitral valve repair Devices Market in the US (2021-2030)
  • Figure 11: Transcatheter mitral valve repair Devices Market in Canada (2021-2030)
  • Figure 12: Transcatheter mitral valve repair Devices Market in Mexico (2021-2030)
  • Figure 13: Transcatheter mitral valve repair Devices Market in Europe (2021-2030)
  • Figure 14: Transcatheter mitral valve repair Devices Market in Europe by Country (2021-2030)
  • Figure 15: Transcatheter mitral valve repair Devices Market in France (2021-2030)
  • Figure 16: Transcatheter mitral valve repair Devices Market in Germany (2021-2030)
  • Figure 17: Transcatheter mitral valve repair Devices Market in the United Kingdom (2021-2030)
  • Figure 18: Transcatheter mitral valve repair Devices Market in Italy (2021-2030)
  • Figure 19: Transcatheter mitral valve repair Devices Market in Spain (2021-2030)
  • Figure 20: Transcatheter mitral valve repair Devices Market in the Rest of Europe (2021-2030)
  • Figure 21: Transcatheter mitral valve repair Devices Market in Asia-Pacific (2021-2030)
  • Figure 22: Transcatheter mitral valve repair Devices Market in Asia-Pacific by Country (2021-2030)
  • Figure 23: Transcatheter mitral valve repair Devices Market in China (2021-2030)
  • Figure 24: Transcatheter mitral valve repair Devices Market in Japan (2021-2030)
  • Figure 25: Transcatheter mitral valve repair Devices Market in India (2021-2030)
  • Figure 26: Transcatheter mitral valve repair Devices Market in Australia (2021-2030)
  • Figure 27: Transcatheter mitral valve repair Devices Market in South Korea (2021-2030)
  • Figure 28: Transcatheter mitral valve repair Devices Market in Rest of Asia-Pacific (2021-2030)
  • Figure 29: Transcatheter mitral valve repair Devices Market in the Rest of the World (2021-2030)
  • Figure 30: Transcatheter mitral valve repair Devices Market in RoW by Region (2021-2030)
  • Figure 31: Transcatheter mitral valve repair Devices Market in the Middle East (2021-2030)
  • Figure 32: Transcatheter mitral valve repair Devices Market in Africa (2021-2030)
  • Figure 33: Transcatheter mitral valve repair Devices Market in South America (2021-2030)
  • Figure 34: Market Drivers
  • Figure 35: Market Barriers
  • Figure 36: Marker Opportunities
  • Figure 37: PORTER'S Five Force Analysis